US22407B1089 - COYA (XNAS)
Coya Therapeutics, Inc. - Common Stock Acción
5,42 USD
Cotizaciones actuales de Coya Therapeutics, Inc. - Common Stock
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NASDAQ |
COYA
|
USD
|
24.12.2024 18:54
|
5,42 USD
| 5,34 USD | 1,40 % |
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 4,13 % | -15,97 % | -9,45 % | -8,22 % | -22,42 % | 18,49 % |
Perfil de la empresa para Coya Therapeutics, Inc. - Common Stock Acción
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous and/or intravenous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an allogeneic Treg exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company was incorporated in 2020 and is headquartered in Houston, Texas.
Datos de la empresa para Coya Therapeutics, Inc. - Common Stock Acción
Nombre Coya Therapeutics, Inc. - Common Stock
Empresa Coya Therapeutics, Inc.
Símbolo COYA
Sitio web https://www.coyatherapeutics.com
Mercado principal
NASDAQ
ISIN US22407B1089
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Dr. Arun Swaminathan Ph.D.
Capitalización de mercado 151 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,0 T
Dirección 5850 San Felipe Street, 77057 Houston
Fecha de OPV 2022-12-29
Símbolos de cotización
Nombre | Símbolo |
---|---|
NASDAQ | COYA |
Otras acciones
Los inversores que tienen Coya Therapeutics, Inc. - Common Stock también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.